Skip to main content
. Author manuscript; available in PMC: 2014 Jul 23.
Published in final edited form as: Endocr Pract. 2013 Jan-Feb;19(1):107–116. doi: 10.4158/endp.19.1.v767575m65p5mr06

Table 1.

Clinical Findings of the Major Lipodystrophy Subtypes

CGL FPL AGL APL
Age range of onset Infancy
to early
childhood
Childhood
through
adulthood
Childhood
through
adulthood
Childhood
through
adulthood
Approximate gender
distribution (male:female)
1:1-2 1:1-2a 1:3 1:4
Fat loss locations
Face and neck X X X
Chest/trunk X + X X
Upper extremities X X X X
Lower extremities X X X
Intra-abdominal X +
Fat accumulation/sparing
Face and neck +
Hips and buttocks +
Lower extremities +
Intra-abdominal + + +
Other findings
Accelerated linear growth +
Acromegaloid features +
Umbilical prominence +
Panniculitis +
Hepatomegaly + + +
Splenomegaly + +
Acanthosis nigricans + + +
Hirsutism + + +
Hyperphagia + + +
Hypogonadism + +
Hyperandrogenism in females + +

Abbreviations: AGL = acquired generalized lipodystrophy; APL = acquired partial lipodystrophy; CGL = congenital generalized lipodystrophy; FPL = familial partial lipodystrophy; X = essential finding; + = finding may be present.

a

FPL is typically more readily recognized in females and affects females more severely.